Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 850 mg Tablets Under Fed Conditions.

Clinical trial NCT07633028 · COMPLETED

Trial details

NCT number: NCT07633028
Sponsor: ADIUM
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bioequivalence Study in Healthy Subjects

Start date: 2025-02-10
Primary completion: 2025-04-08
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.